AXSM
Axsome Therapeutics, Inc.
Nasdaq: AXSM · New York, NY · Healthcare
$241.00-0.53 (-0.22%)Closed
Market Cap$12.39B
Cash$305.1Mmost recent
Runway44 mo$20.7M Q burn
P/E (TTM)—EPS $-3.68
52-Wk Range$100.39 – $255.17
Avg Volume679.8K3-month
Price & Trading Activity
Daily close with catalyst overlays and trading volume
$241.00+180.3%
Pipeline
Drug candidates sponsored by AXSM · ClinicalTrials.gov
Couldn't load pipeline. ClinicalTrials.gov or the backend may be unavailable.
Valuation
Risk-adjusted NPV
Loading pipeline…
Peer comparison
Cohort check
No peer cohort defined for AXSM. Cohorts currently cover gene editing, mRNA, rare-disease gene therapy, and large-cap biotech — more coming soon.